Cargando…

Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases

Purpose: The relationship of clinical results and survival analysis of operative patients with petroclival meningioma (PCM) was studied. Patients and methods: Data from a total of 176 PCM patients receiving surgical resection were retrospectively collected. Follow-up was conducted through outpatient...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiao, Li, Yu, Chunjiang, Zhang, Hongwei, Zhang, Mingshan, Qu, Yanming, Ren, Ming, Gu, Chunyu, Wang, Haoran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612996/
https://www.ncbi.nlm.nih.gov/pubmed/31308738
http://dx.doi.org/10.2147/CMAR.S200932
_version_ 1783432978041405440
author Qiao, Li
Yu, Chunjiang
Zhang, Hongwei
Zhang, Mingshan
Qu, Yanming
Ren, Ming
Gu, Chunyu
Wang, Haoran
author_facet Qiao, Li
Yu, Chunjiang
Zhang, Hongwei
Zhang, Mingshan
Qu, Yanming
Ren, Ming
Gu, Chunyu
Wang, Haoran
author_sort Qiao, Li
collection PubMed
description Purpose: The relationship of clinical results and survival analysis of operative patients with petroclival meningioma (PCM) was studied. Patients and methods: Data from a total of 176 PCM patients receiving surgical resection were retrospectively collected. Follow-up was conducted through outpatient review by reexamination telephone calls and letters. Clinical outcomes, survival, and Karnofsky Performance Scale (KPS) data were analyzed. Results: Seventy-two percent of patients (127/176) received only surgery, 8.5% (15/176) received surgery and adjuvant radiation therapy (RT) (surgery + RT), and 19.3% (34/176) received surgery and adjuvant gamma knife surgery (GKS) (surgery + GKS). Gross total resection (GTR) was performed in 34.7% of patients (61/176), subtotal resection (STR) in 58.0% (102/176), and partial resection (PR) in 7.4% (13/176). Recent follow-up KPS was higher than preoperative (80 vs 70, P<0.05) and postoperative KPS (80 vs 70, P<0.05). Cumulative survival was the same for 3, 5, 7, and 9 years, ie, 95%, and mean survival time (MST) was (110.83±2.55) months (95% CI: 105.83–115.83). Recurrence/progression (R/P)-free survival was 88.9%, 86.9%, 71.1% and 71.1%, respectively for 3, 5, 7, and 9 years, and MST was (100.58±3.82) months (95% CI: 93.11–108.06). R/P (HR: 5.486, 95% CI: 1.655–18.180), surgery + RT (HR: 0.125, 95% CI: 0.016–0.990) and WHO grade III (HR: 2.766, 95% CI: 1.146–6.676) were independently associated with cumulative survival. Lack of adhesion to and encasement of neurovascular structures was independently associated with R/P-free survival (HR: 2.002, 95% CI: 1.023–3.919). Conclusion: Surgical treatment was safe and effective for PCM. R/P, surgery + RT, and WHO grade III were independently associated with cumulative survival. Lack of adhesion to and encasement of neurovascular structures was independently associated with R/P-free survival. These factors should be paid attention to in surgical treatment of PCM.
format Online
Article
Text
id pubmed-6612996
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66129962019-07-15 Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases Qiao, Li Yu, Chunjiang Zhang, Hongwei Zhang, Mingshan Qu, Yanming Ren, Ming Gu, Chunyu Wang, Haoran Cancer Manag Res Original Research Purpose: The relationship of clinical results and survival analysis of operative patients with petroclival meningioma (PCM) was studied. Patients and methods: Data from a total of 176 PCM patients receiving surgical resection were retrospectively collected. Follow-up was conducted through outpatient review by reexamination telephone calls and letters. Clinical outcomes, survival, and Karnofsky Performance Scale (KPS) data were analyzed. Results: Seventy-two percent of patients (127/176) received only surgery, 8.5% (15/176) received surgery and adjuvant radiation therapy (RT) (surgery + RT), and 19.3% (34/176) received surgery and adjuvant gamma knife surgery (GKS) (surgery + GKS). Gross total resection (GTR) was performed in 34.7% of patients (61/176), subtotal resection (STR) in 58.0% (102/176), and partial resection (PR) in 7.4% (13/176). Recent follow-up KPS was higher than preoperative (80 vs 70, P<0.05) and postoperative KPS (80 vs 70, P<0.05). Cumulative survival was the same for 3, 5, 7, and 9 years, ie, 95%, and mean survival time (MST) was (110.83±2.55) months (95% CI: 105.83–115.83). Recurrence/progression (R/P)-free survival was 88.9%, 86.9%, 71.1% and 71.1%, respectively for 3, 5, 7, and 9 years, and MST was (100.58±3.82) months (95% CI: 93.11–108.06). R/P (HR: 5.486, 95% CI: 1.655–18.180), surgery + RT (HR: 0.125, 95% CI: 0.016–0.990) and WHO grade III (HR: 2.766, 95% CI: 1.146–6.676) were independently associated with cumulative survival. Lack of adhesion to and encasement of neurovascular structures was independently associated with R/P-free survival (HR: 2.002, 95% CI: 1.023–3.919). Conclusion: Surgical treatment was safe and effective for PCM. R/P, surgery + RT, and WHO grade III were independently associated with cumulative survival. Lack of adhesion to and encasement of neurovascular structures was independently associated with R/P-free survival. These factors should be paid attention to in surgical treatment of PCM. Dove 2019-07-01 /pmc/articles/PMC6612996/ /pubmed/31308738 http://dx.doi.org/10.2147/CMAR.S200932 Text en © 2019 Qiao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Qiao, Li
Yu, Chunjiang
Zhang, Hongwei
Zhang, Mingshan
Qu, Yanming
Ren, Ming
Gu, Chunyu
Wang, Haoran
Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
title Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
title_full Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
title_fullStr Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
title_full_unstemmed Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
title_short Clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
title_sort clinical outcomes and survival analysis for petroclival meningioma patients receiving surgical resection: an analysis of 176 cases
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6612996/
https://www.ncbi.nlm.nih.gov/pubmed/31308738
http://dx.doi.org/10.2147/CMAR.S200932
work_keys_str_mv AT qiaoli clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases
AT yuchunjiang clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases
AT zhanghongwei clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases
AT zhangmingshan clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases
AT quyanming clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases
AT renming clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases
AT guchunyu clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases
AT wanghaoran clinicaloutcomesandsurvivalanalysisforpetroclivalmeningiomapatientsreceivingsurgicalresectionananalysisof176cases